- Home
- DTSS vs CSCI Comparison
DTSS vs CSCI Comparison
Compare DTSS & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- CSCI
- Stock Information
- Founded
- DTSS 2014
- CSCI 1990
- Country
- DTSS China
- CSCI Canada
- Employees
- DTSS N/A
- CSCI N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- CSCI
- Sector
- DTSS Technology
- CSCI
- Exchange
- DTSS Nasdaq
- CSCI NYSE
- Market Cap
- DTSS 10.3M
- CSCI 11.5M
- IPO Year
- DTSS N/A
- CSCI 1996
- Fundamental
- Price
- DTSS $2.21
- CSCI $3.70
- Analyst Decision
- DTSS
- CSCI
- Analyst Count
- DTSS 0
- CSCI 0
- Target Price
- DTSS N/A
- CSCI N/A
- AVG Volume (30 Days)
- DTSS 944.8K
- CSCI 4.9K
- Earning Date
- DTSS 11-11-2024
- CSCI 11-07-2024
- Dividend Yield
- DTSS N/A
- CSCI N/A
- EPS Growth
- DTSS N/A
- CSCI N/A
- EPS
- DTSS N/A
- CSCI N/A
- Revenue
- DTSS $23,975,867.00
- CSCI $4,915,000.00
- Revenue This Year
- DTSS N/A
- CSCI N/A
- Revenue Next Year
- DTSS N/A
- CSCI N/A
- P/E Ratio
- DTSS N/A
- CSCI N/A
- Revenue Growth
- DTSS 558.55
- CSCI N/A
- 52 Week Low
- DTSS $1.42
- CSCI $3.49
- 52 Week High
- DTSS $20.29
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- DTSS 48.85
- CSCI N/A
- Support Level
- DTSS $2.11
- CSCI N/A
- Resistance Level
- DTSS $2.49
- CSCI N/A
- Average True Range (ATR)
- DTSS 0.24
- CSCI 0.00
- MACD
- DTSS -0.01
- CSCI 0.00
- Stochastic Oscillator
- DTSS 15.71
- CSCI 0.00
About DTSS Datasea Inc.
Datasea Inc is a development stage company engaged in Internet security products. Its offers service and products such as Internet Security Equipment, New Media Advertising Service, Micro Marketing Service, Internet Service Provider (ISP) Connecting Service, Big Data Processing Service. The business activity of the group functions through China.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.